Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00241748 · ClinicalTrials.gov registry record
Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event
A clinical trial of Rhabdomyolysis, sponsored by University of Washington.
- Completed
- Registry status
- 187
- Enrollment target
- 1
- Study location
NCT00241748 is a study of Rhabdomyolysis that has completed, run by University of Washington. The registered enrollment target is 187 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00241748, a study of Rhabdomyolysis, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 187 participants
- Enrollment target
- 1
- Study location
Study Summary
To conduct a case-control study of factors that increased the risk of rhabdomyolysis, an adverse drug reaction in cerivastatin users
Conditions Studied
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2005-09 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00241748
The ClinicalTrials.gov registry entry for NCT00241748 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 187 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rhabdomyolysis appearing as the primary indexed condition, and to 0 interventions.
NCT00241748 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00241748 about?
NCT00241748 is a clinical study titled "Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event". To conduct a case-control study of factors that increased the risk of rhabdomyolysis, an adverse drug reaction in cerivastatin users
What is the current status of trial NCT00241748?
This trial is currently completed. The enrollment target is 187 participants. The study started on 2005-09. Estimated completion is 2011-12.
What conditions does trial NCT00241748 study?
This clinical trial studies the following conditions: Rhabdomyolysis.
Who is sponsoring clinical trial NCT00241748?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00241748 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rhabdomyolysis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.